WO1996022375A2 - Procedures et materiaux destines a conferer a des plantes la resistance a des maladies - Google Patents
Procedures et materiaux destines a conferer a des plantes la resistance a des maladies Download PDFInfo
- Publication number
- WO1996022375A2 WO1996022375A2 PCT/US1996/000717 US9600717W WO9622375A2 WO 1996022375 A2 WO1996022375 A2 WO 1996022375A2 US 9600717 W US9600717 W US 9600717W WO 9622375 A2 WO9622375 A2 WO 9622375A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- plant
- seq
- rrk
- sequence
- promoter
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 63
- 208000035240 Disease Resistance Diseases 0.000 title description 12
- 239000000463 material Substances 0.000 title description 6
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 30
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 28
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 28
- 229920001184 polypeptide Polymers 0.000 claims abstract description 23
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 23
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 23
- 230000009261 transgenic effect Effects 0.000 claims abstract description 14
- 241000589634 Xanthomonas Species 0.000 claims abstract description 12
- 108090000623 proteins and genes Proteins 0.000 claims description 126
- 241000196324 Embryophyta Species 0.000 claims description 104
- 108091033319 polynucleotide Proteins 0.000 claims description 47
- 102000040430 polynucleotide Human genes 0.000 claims description 47
- 239000002157 polynucleotide Substances 0.000 claims description 47
- 235000007164 Oryza sativa Nutrition 0.000 claims description 30
- 235000009566 rice Nutrition 0.000 claims description 29
- 210000004901 leucine-rich repeat Anatomy 0.000 claims description 21
- 241000227653 Lycopersicon Species 0.000 claims description 20
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims description 17
- 150000001413 amino acids Chemical group 0.000 claims description 14
- 239000002299 complementary DNA Substances 0.000 claims description 13
- 230000003321 amplification Effects 0.000 claims description 10
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 10
- 238000003259 recombinant expression Methods 0.000 claims description 7
- 108010006444 Leucine-Rich Repeat Proteins Proteins 0.000 claims description 5
- 108050002122 Protein kinase domains Proteins 0.000 claims description 5
- 102000012515 Protein kinase domains Human genes 0.000 claims description 5
- 230000001086 cytosolic effect Effects 0.000 claims description 5
- 206010034133 Pathogen resistance Diseases 0.000 claims description 2
- 230000002708 enhancing effect Effects 0.000 claims description 2
- 241000209094 Oryza Species 0.000 claims 2
- 244000052769 pathogen Species 0.000 abstract description 7
- 230000001717 pathogenic effect Effects 0.000 abstract description 5
- 108020004414 DNA Proteins 0.000 description 69
- 240000007594 Oryza sativa Species 0.000 description 30
- 235000018102 proteins Nutrition 0.000 description 28
- 102000004169 proteins and genes Human genes 0.000 description 28
- 210000004436 artificial bacterial chromosome Anatomy 0.000 description 23
- 239000013598 vector Substances 0.000 description 22
- 239000012634 fragment Substances 0.000 description 20
- 210000004027 cell Anatomy 0.000 description 19
- 238000003752 polymerase chain reaction Methods 0.000 description 15
- 239000000523 sample Substances 0.000 description 15
- 235000001014 amino acid Nutrition 0.000 description 14
- 239000000243 solution Substances 0.000 description 14
- 210000001519 tissue Anatomy 0.000 description 14
- 229940024606 amino acid Drugs 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 230000014509 gene expression Effects 0.000 description 12
- 230000009466 transformation Effects 0.000 description 12
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 11
- 108091000080 Phosphotransferase Proteins 0.000 description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 239000000872 buffer Substances 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 10
- 102000020233 phosphotransferase Human genes 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 101100165929 Arabidopsis thaliana CRK6 gene Proteins 0.000 description 9
- 101100037317 Arabidopsis thaliana RLK5 gene Proteins 0.000 description 9
- 125000003275 alpha amino acid group Chemical group 0.000 description 9
- 238000002955 isolation Methods 0.000 description 9
- 239000008188 pellet Substances 0.000 description 9
- 241000894007 species Species 0.000 description 9
- 239000000499 gel Substances 0.000 description 8
- 239000003550 marker Substances 0.000 description 8
- 229920000936 Agarose Polymers 0.000 description 7
- 108091028043 Nucleic acid sequence Proteins 0.000 description 7
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 238000004520 electroporation Methods 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 238000009396 hybridization Methods 0.000 description 6
- 230000004048 modification Effects 0.000 description 6
- 238000012986 modification Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 241000589158 Agrobacterium Species 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 238000013459 approach Methods 0.000 description 5
- 230000000295 complement effect Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 108020004999 messenger RNA Proteins 0.000 description 5
- 239000013612 plasmid Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 238000003906 pulsed field gel electrophoresis Methods 0.000 description 5
- 230000008929 regeneration Effects 0.000 description 5
- 238000011069 regeneration method Methods 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- 108010067770 Endopeptidase K Proteins 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- 108700001094 Plant Genes Proteins 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 238000007792 addition Methods 0.000 description 4
- 230000000680 avirulence Effects 0.000 description 4
- 230000027455 binding Effects 0.000 description 4
- 238000012512 characterization method Methods 0.000 description 4
- 229960005091 chloramphenicol Drugs 0.000 description 4
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 4
- 238000010367 cloning Methods 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 239000002773 nucleotide Substances 0.000 description 4
- 125000003729 nucleotide group Chemical group 0.000 description 4
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 210000001938 protoplast Anatomy 0.000 description 4
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 4
- PFNFFQXMRSDOHW-UHFFFAOYSA-N spermine Chemical compound NCCCNCCCCNCCCN PFNFFQXMRSDOHW-UHFFFAOYSA-N 0.000 description 4
- 238000010561 standard procedure Methods 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- 241000219194 Arabidopsis Species 0.000 description 3
- 239000004475 Arginine Substances 0.000 description 3
- 108020004705 Codon Proteins 0.000 description 3
- 108010061982 DNA Ligases Proteins 0.000 description 3
- 102000012410 DNA Ligases Human genes 0.000 description 3
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 241000209510 Liliopsida Species 0.000 description 3
- 108091005682 Receptor kinases Proteins 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 101150019400 TMK1 gene Proteins 0.000 description 3
- 241000607479 Yersinia pestis Species 0.000 description 3
- 241000209149 Zea Species 0.000 description 3
- 238000000137 annealing Methods 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 210000000349 chromosome Anatomy 0.000 description 3
- 238000012217 deletion Methods 0.000 description 3
- 230000037430 deletion Effects 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 210000004940 nucleus Anatomy 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 238000013518 transcription Methods 0.000 description 3
- 230000035897 transcription Effects 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 2
- 101100061426 Arabidopsis thaliana CRK10 gene Proteins 0.000 description 2
- 101100309717 Arabidopsis thaliana SD22 gene Proteins 0.000 description 2
- 241000701489 Cauliflower mosaic virus Species 0.000 description 2
- -1 Cf-9 Proteins 0.000 description 2
- 108020004635 Complementary DNA Proteins 0.000 description 2
- 108091035707 Consensus sequence Proteins 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 206010020649 Hyperkeratosis Diseases 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- 244000147568 Laurus nobilis Species 0.000 description 2
- 235000017858 Laurus nobilis Nutrition 0.000 description 2
- 239000006137 Luria-Bertani broth Substances 0.000 description 2
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 2
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 2
- 102000001253 Protein Kinase Human genes 0.000 description 2
- 108010009341 Protein Serine-Threonine Kinases Proteins 0.000 description 2
- 102000009516 Protein Serine-Threonine Kinases Human genes 0.000 description 2
- 241000589615 Pseudomonas syringae Species 0.000 description 2
- 101710140185 Receptor-like protein kinase Proteins 0.000 description 2
- 108020004511 Recombinant DNA Proteins 0.000 description 2
- 102000014400 SH2 domains Human genes 0.000 description 2
- 108050003452 SH2 domains Proteins 0.000 description 2
- 108010077895 Sarcosine Proteins 0.000 description 2
- 241000209056 Secale Species 0.000 description 2
- 108700026226 TATA Box Proteins 0.000 description 2
- 101150008358 TRK1 gene Proteins 0.000 description 2
- 235000005212 Terminalia tomentosa Nutrition 0.000 description 2
- 101710097146 Uncharacterized protein HKLF1 Proteins 0.000 description 2
- 241001272684 Xanthomonas campestris pv. oryzae Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- 125000000539 amino acid group Chemical group 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 238000003491 array Methods 0.000 description 2
- 239000003139 biocide Substances 0.000 description 2
- 210000003763 chloroplast Anatomy 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 244000038559 crop plants Species 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 2
- 229960005542 ethidium bromide Drugs 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 230000002363 herbicidal effect Effects 0.000 description 2
- 239000004009 herbicide Substances 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 108091005573 modified proteins Proteins 0.000 description 2
- 102000035118 modified proteins Human genes 0.000 description 2
- 239000004570 mortar (masonry) Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 229920002113 octoxynol Polymers 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 108060006633 protein kinase Proteins 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- 102000005962 receptors Human genes 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229940043230 sarcosine Drugs 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 229940063673 spermidine Drugs 0.000 description 2
- 229940063675 spermine Drugs 0.000 description 2
- 238000010025 steaming Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 230000005026 transcription initiation Effects 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 239000004474 valine Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- BEJKOYIMCGMNRB-GRHHLOCNSA-N (2s)-2-amino-3-(4-hydroxyphenyl)propanoic acid;(2s)-2-amino-3-phenylpropanoic acid Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1.OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 BEJKOYIMCGMNRB-GRHHLOCNSA-N 0.000 description 1
- YUXKOWPNKJSTPQ-AXWWPMSFSA-N (2s,3r)-2-amino-3-hydroxybutanoic acid;(2s)-2-amino-3-hydroxypropanoic acid Chemical compound OC[C@H](N)C(O)=O.C[C@@H](O)[C@H](N)C(O)=O YUXKOWPNKJSTPQ-AXWWPMSFSA-N 0.000 description 1
- ZBMRKNMTMPPMMK-UHFFFAOYSA-N 2-amino-4-[hydroxy(methyl)phosphoryl]butanoic acid;azane Chemical compound [NH4+].CP(O)(=O)CCC(N)C([O-])=O ZBMRKNMTMPPMMK-UHFFFAOYSA-N 0.000 description 1
- OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 1
- 241000207875 Antirrhinum Species 0.000 description 1
- 241000219195 Arabidopsis thaliana Species 0.000 description 1
- 101100393868 Arabidopsis thaliana GT11 gene Proteins 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 244000003416 Asparagus officinalis Species 0.000 description 1
- 235000005340 Asparagus officinalis Nutrition 0.000 description 1
- 241001106067 Atropa Species 0.000 description 1
- 235000005781 Avena Nutrition 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 241000228439 Bipolaris zeicola Species 0.000 description 1
- 108010006654 Bleomycin Proteins 0.000 description 1
- 241000219198 Brassica Species 0.000 description 1
- 235000011331 Brassica Nutrition 0.000 description 1
- 101100043398 Brassica oleracea var. viridis SRK6 gene Proteins 0.000 description 1
- 241000209200 Bromus Species 0.000 description 1
- 101100008049 Caenorhabditis elegans cut-5 gene Proteins 0.000 description 1
- 101100419062 Caenorhabditis elegans rps-2 gene Proteins 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 108091028732 Concatemer Proteins 0.000 description 1
- 244000024469 Cucumis prophetarum Species 0.000 description 1
- 235000010071 Cucumis prophetarum Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 238000007399 DNA isolation Methods 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 241000208296 Datura Species 0.000 description 1
- 241000208175 Daucus Species 0.000 description 1
- 240000001879 Digitalis lutea Species 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 241000220223 Fragaria Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- 241000208152 Geranium Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000208818 Helianthus Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101001059454 Homo sapiens Serine/threonine-protein kinase MARK2 Proteins 0.000 description 1
- 241000209219 Hordeum Species 0.000 description 1
- 241000208278 Hyoscyamus Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000758789 Juglans Species 0.000 description 1
- 235000013757 Juglans Nutrition 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 241000208822 Lactuca Species 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 241000208204 Linum Species 0.000 description 1
- 241000209082 Lolium Species 0.000 description 1
- 235000002262 Lycopersicon Nutrition 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241001330975 Magnaporthe oryzae Species 0.000 description 1
- 241000121629 Majorana Species 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 241000219823 Medicago Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 241001282315 Nemesis Species 0.000 description 1
- 241000208125 Nicotiana Species 0.000 description 1
- 238000000636 Northern blotting Methods 0.000 description 1
- 108091093105 Nuclear DNA Proteins 0.000 description 1
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
- 241000219830 Onobrychis Species 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 108091092740 Organellar DNA Proteins 0.000 description 1
- 240000003010 Oryza longistaminata Species 0.000 description 1
- 241000222291 Passalora fulva Species 0.000 description 1
- 241000208181 Pelargonium Species 0.000 description 1
- 241000209046 Pennisetum Species 0.000 description 1
- 240000007377 Petunia x hybrida Species 0.000 description 1
- 241000219833 Phaseolus Species 0.000 description 1
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
- 241000219843 Pisum Species 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 102000002007 Proto-Oncogene Proteins pp60(c-src) Human genes 0.000 description 1
- 108010015730 Proto-Oncogene Proteins pp60(c-src) Proteins 0.000 description 1
- 101100492348 Pseudomonas syringae pv. tomato avrRpt2 gene Proteins 0.000 description 1
- 101100083082 Pyrus communis PGIP gene Proteins 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 241000218206 Ranunculus Species 0.000 description 1
- 241000220259 Raphanus Species 0.000 description 1
- 241000714474 Rous sarcoma virus Species 0.000 description 1
- 241001106018 Salpiglossis Species 0.000 description 1
- 241000780602 Senecio Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 102100028904 Serine/threonine-protein kinase MARK2 Human genes 0.000 description 1
- 241000220261 Sinapis Species 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 235000002634 Solanum Nutrition 0.000 description 1
- 241000207763 Solanum Species 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 108700009124 Transcription Initiation Site Proteins 0.000 description 1
- 108700019146 Transgenes Proteins 0.000 description 1
- 241000219793 Trifolium Species 0.000 description 1
- 241001312519 Trigonella Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 241000219977 Vigna Species 0.000 description 1
- 241000815873 Xanthomonas euvesicatoria Species 0.000 description 1
- 241000589652 Xanthomonas oryzae Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N adenyl group Chemical class N1=CN=C2N=CNC2=C1N GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 229960001561 bleomycin Drugs 0.000 description 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000001390 capsicum minimum Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- ZYWFEOZQIUMEGL-UHFFFAOYSA-N chloroform;3-methylbutan-1-ol;phenol Chemical compound ClC(Cl)Cl.CC(C)CCO.OC1=CC=CC=C1 ZYWFEOZQIUMEGL-UHFFFAOYSA-N 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 230000001332 colony forming effect Effects 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000013601 cosmid vector Substances 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000004665 defense response Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000408 embryogenic effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 238000012252 genetic analysis Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000004068 intracellular signaling Effects 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 238000001738 isopycnic centrifugation Methods 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 238000000464 low-speed centrifugation Methods 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 235000005739 manihot Nutrition 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 208000024191 minimally invasive lung adenocarcinoma Diseases 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 230000009456 molecular mechanism Effects 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 238000007899 nucleic acid hybridization Methods 0.000 description 1
- 239000002853 nucleic acid probe Substances 0.000 description 1
- 239000002751 oligonucleotide probe Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- DCWXELXMIBXGTH-UHFFFAOYSA-N phosphotyrosine Chemical group OC(=O)C(N)CC1=CC=C(OP(O)(O)=O)C=C1 DCWXELXMIBXGTH-UHFFFAOYSA-N 0.000 description 1
- 229930195732 phytohormone Natural products 0.000 description 1
- 244000000003 plant pathogen Species 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 230000008488 polyadenylation Effects 0.000 description 1
- 102000054765 polymorphisms of proteins Human genes 0.000 description 1
- 238000012809 post-inoculation Methods 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000004850 protein–protein interaction Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- NHDHVHZZCFYRSB-UHFFFAOYSA-N pyriproxyfen Chemical compound C=1C=CC=NC=1OC(C)COC(C=C1)=CC=C1OC1=CC=CC=C1 NHDHVHZZCFYRSB-UHFFFAOYSA-N 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 101150060482 rps2 gene Proteins 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 230000014621 translational initiation Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
- C12N15/8281—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for bacterial resistance
Definitions
- the present invention relates generally to plant molecular biology.
- it relates to nucleic acids and methods for conferring disease resistance in plants.
- Loci conferring disease resistance have been identified in many plant species. Genetic analysis of many plant-pathogen interactions has demonstrated that plants contain loci that confer resistance against specific races of a pathogen containing a complementary avirulence gene. Molecular characterization of these genes should provide means for conferring disease resistance to a wide variety of crop plants.
- Those plant resistance genes that have been characterized at the molecular level fall into four classes.
- the Pto gene confers resistance against Pseudomonas syringae that express the avrPto avirulence gene (Martin et al. Science 262:1432 (1993)).
- the predicted Pto gene encodes a serine threonine protein kinase.
- the tomato Cf-9 gene confers resistance to races of the fungus Cladosporium fulvum that carry the avirulence gene Avr9 (Jones et al. Science 266:789- 793 (1994).
- the tomato Cf-9 gene encodes a putatitive extracellular LRR protein.
- the RPS2 gene of Arabidopsis thaliana confers resistance to P. syringae that express the avrRpt2 avirulence gene (Bent et al. Science 265: 1856-1860 (1994)).
- RPs2 encodes a protein with an LRR motif and a P-loop motif.
- Bacterial blight disease caused by Xanthomonas spp. infects virtually all crop plants and leads to extensive crop losses worldwide.
- Bacterial blight disease of rice (Oryza sativa), caused by Xanthomonas oryzae pv. oryzae (Xoo), is an important disease of this crop. Races of Xoo that induce resistant or susceptible reactions on rice cultivars with distinct resistance (Xa) genes have been identified.
- One source of resistance (Xa21) had been identified in the wild species Oryza longistaminata (Khush et al. in Proceedings of the International Workshop on Bacterial Blight of Rice. (International Rice Research Institute, 1989) and Ikeda et al. Jpn J.
- Xa21 is a dominant resistance locus that confers resistance to all known isolates of Xoo and is the only characterized Xa gene that carries resistance to Xoo race 6. Genetic and physical analysis of the Xa21 locus has identified a number of tightly linked markers on chromosome 11 (Ronald et al. Mol. Gen. Genet. 236: 113-120 (1992)). The molecular mechanisms by which the Xa21 locus confers resistance to this pathogen were not identified, however.
- the present invention provides isolated nucleic acid constructs comprising an RRK polynucleotide sequence, which hybridizes to SEQ. ID. No. 1 or to SEQ. ID. No. 3 under stringent conditions.
- Exemplary RRK polynucleotide sequences are Xa21 sequences which encode an Xa21 polypeptide as shown in SEQ. ID. No. 4.
- the RRK polynucleotides encode a protein having a leucine rich repeat motif and/or a cytoplasmic protein kinase domain.
- the nucleic acid constructs of the invention may further comprise a promoter operably linked to the RRK polynucleotide sequence.
- the promoter may be a tissue-specific promoter or a constitutive promoter.
- the invention also provides nucleic acid constructs comprising a promoter sequence from an RRK gene linked to a heterologous polynucleotide sequence.
- heterologous polynucleotide sequences include structural genes which confer pathogen resistance on plants.
- the invention further provides transgenic plants comprising a recombinant expression cassette comprising a promoter from an RRK gene operably linked to a polynucleotide sequence as well as transgenic plants comprising a recombinant expression cassette comprising a plant promoter operably linked to an RRK polynucleotide sequence.
- transgenic plants comprising a recombinant expression cassette comprising a promoter from an RRK gene operably linked to a polynucleotide sequence
- transgenic plants comprising a recombinant expression cassette comprising a plant promoter operably linked to an RRK polynucleotide sequence.
- rice and tomato plants may be conveniently used.
- the invention further provides methods of enhancing resistance to
- the methods comprise introducing into the plant a recombinant expression cassette comprising a plant promoter operably linked to an RRK
- polynucleotide sequence The methods may be conveniently carried out with rice or tomato plants.
- plant includes whole plants, plant organs (e.g., leaves, stems, roots, etc.), seeds and plant cells and progeny of same.
- plant organs e.g., leaves, stems, roots, etc.
- the class of plants which can be used in the methods of the invention is generally as broad as the class of higher plants amenable to transformation techniques, including both monocotyledonous and
- heterologous sequence is one that originates from a foreign species, or, if from the same species, is substantially modified from its original form.
- a promoter operably linked to a heterologous structural gene is from a species different from that from which the structural gene was derived, or, if from the same species, one or both are substantially modified from their original form.
- RRK gene is member of a new class of disease resistance genes which encode RRK polypeptides comprising an extracellular LRR domain, a
- an LRR domain is a region of a repeated unit of about 24 residues as shown in Figure 1 and found in Cf-9 and RLK5).
- a nucleic acid probe from an Xa21 gene detected polymorphisms that segregated with the blast (Pyricularia oryzae) resistance gene (Pi7) in 58 recombinant inbred lines of rice.
- the same probe also detected polymorphism in nearly isogenic lines carrying xa5 and Xa10 resistance genes.
- members of this class of disease resistance genes can be identified by their ability to be amplified by degenerate PCR primers which correpsond to the LRR and kinase domains.
- primers have been used to isolate homologous genes in tomato.
- Exemplary primers for this purpose are tcaagcaacaatttgtcaggnca a/g at a/c/t cc (for the LRR domain sequence GQIP) and taacagcacattgcttgatttnan g/a tcncg g/a tg (the kinase domain sequence HCDIK).
- Xa21 polynucleotide sequence is a subsequence or full length polynucleotide sequence of an Xa21 gene, such as the rice Xa21 gene, which, when present in a transgenic plant confers resistance to Xanthomonas spp. (e.g. , X. oryzae) on the plant.
- exemplary polynucleotides of the invention include the coding region of SEQ. ID. No. 3.
- An Xa21 polynucleotide is typically at least about 3100 nucleotides to about 6500 nucleotides in length, usually from about 4000 to about 4500 nucleotides.
- Xa21 polypeptide is a gene product of an Xa21 polynucleotide sequence, which has the activity of Xa21, i.e., the ability to confer resistance to
- Xanthomonas spp. Xa21 polypeptides are characterized by the presence of an extracellular domain comprising a region of leucine rich repeats
- Exemplary Xa21 polypeptides of the invention include SEQ. ID. No. 4.
- transgenes In the expression of transgenes one of skill will recognize that the inserted polynucleotide sequence need not be identical and may be "substantially identical" to a sequence of the gene from which it was derived. As explained below, these variants are specifically covered by this term.
- polynucleotide sequence specifically includes those full length sequences substantially identical (determined as described below) with an RRK gene sequence and that encode proteins that retain the function of the RRK protein.
- the above term includes variant polynucleotide sequences which have substantial identity with the sequences disclosed here and which encode proteins capable of conferring resistance to Xanthomonas or other plant diseases and pests on a transgenic plant comprising the sequence.
- Two polynucleotides or polypeptides are said to be "identical” if the sequence of nucleotides or amino acid residues, respectively, in the two sequences is the same when aligned for maximum correspondence as described below.
- complementary to is used herein to mean that the complementary sequence is identical to all or a portion of a reference polynucleotide sequence.
- Sequence comparisons between two (or more) polynucleotides or polypeptides are typically performed by comparing sequences of the two sequences over a segment or "comparison window" to identify and compare local regions of sequence similarity.
- the segment used for purposes of comparison may be at least about 20 contiguous positions, usually about 50 to about 200, more usually about 100 to about 150 in which a sequence may be compared to a reference sequence of the same number of contiguous positions after the two sequences are optimally aligned.
- Optimal alignment of sequences for comparison may be conducted by the local homology algorithm of Smith and Waterman Adv. Appl. Math. 2: 482 (1981), by the homology alignment algorithm of Needleman and Wunsch J. Mol. Biol. 48:443 (1970), by the search for similarity method of Pearson and Lipman Proc. Natl. Acad. Sci. (U.S.A.) 85: 2444 (1988), by computerized implementations of these algorithms (GAP, BESTFTT, FASTA, and TFASTA in the Wisconsin Genetics Software Package, Genetics Computer Group (GCG), 575 Science Dr., Madison, WI), or by inspection.
- Percentage of sequence identity is determined by comparing two optimally aligned sequences over a comparison window, wherein the portion of the polynucleotide sequence in the comparison window may comprise additions or deletions (i.e., gaps) as compared to the reference sequence (which does not comprise additions or deletions) for optimal alignment of the two sequences. The percentage is calculated by determining the number of positions at which the identical nucleic acid base or amino acid residue occurs in both sequences to yield the number of matched positions, dividing the number of matched positions by the total number of positions in the window of comparison and multiplying the result by 100 to yield the percentage of sequence identity.
- substantially identical of polynucleotide sequences means that a polynucleotide comprises a sequence that has at least 60% sequence identity, preferably at least 80%, more preferably at least 90% and most preferably at least 95%, compared to a reference sequence using the programs described above (preferably BESTFIT) using standard parameters.
- BESTFIT the programs described above
- One of skill will recognize that these values can be appropriately adjusted to determine corresponding identity of proteins encoded by two nucleotide sequences by taking into account codon degeneracy, amino acid similarity, reading frame positioning and the like.
- Substantial identity of amino acid sequences for these purposes normally means sequence identity of at least 40%, preferably at least 60%, more preferably at least 90%, and most preferably at least 95%.
- substantially similar share sequences as noted above except that residue positions which are not identical may differ by conservative amino acid changes.
- Conservative amino acid substitutions refer to the interchangeability of residues having similar side chains.
- a group of amino acids having aliphatic side chains is glycine, alanine, valine, leucine, and isoleucine
- a group of amino acids having aliphatic-hydroxyl side chains is serine and threonine
- a group of amino acids having amide-containing side chains is asparagine and glutamine
- a group of amino acids having aromatic side chains is phenylalanine, tyrosine, and tryptophan
- a group of amino acids having basic side chains is lysine, arginine, and histidine
- a group of amino acids having sulfur-containing side chains is cysteine and methionine.
- Preferred conservative amino acids substitution groups are: valine-leucine-isoleucine, phenylalanine-tyrosine, lysine
- nucleotide sequences are substantially identical if two molecules hybridize to each other under appropriate conditions.
- Appropriate conditions can be high or low stringency and will be different in different circumstances.
- stringent conditions are selected to be about 5°C to about 20°C lower than the thermal melting point (Tm) for the specific sequence at a defined ionic strength and pH.
- Tm is the temperature (under defined ionic strength and pH) at which 50% of the target sequence hybridizes to a perfectly matched probe.
- stringent wash conditions are those in which the salt concentration is about 0.02 molar at pH 7 and the temperature is at least about 60°C.
- nucleic acids which do not hybridize to each other under stringent conditions are still substantially identical if the polypeptides which they encode are substantially identical. This may occur, e.g., when a copy of a nucleic acid is created using the maximum codon degeneracy permitted by the genetic code.
- high stringency wash conditions will include at least one wash in 0.1X SSC at 65°C.
- Nucleic acids of the invention can be identified from a cDNA or genomic library prepared according to standard procedures and the nucleic acids disclosed here (e.g. , SEQ. ID. Nos. 1 or 3) used as a probe.
- Low stringency hybridization conditions will typically include at least one wash using 2X SSC at 65°C. The washes are preferrably followed by a subsequent wash using IX SSC at 65°C.
- a homolog of a particular RRK gene is a second gene (either in the same species or in a different species) which encodes a protein having an amino acid sequence having at least 25% identity or 45% similiarity to (determined as described above) to a polypeptide sequence in the first gene product. It is believed that, in general, homologs share a common evolutionary past.
- Figure 1 shows a comparison of leucine rich repeat proteins.
- Figure 2A-F show partial restriction maps of BAC and cosmid clones containing regions that hybridized to Xa21-specific probes.
- Figure 3 shows a restriction map of pB822, the most active copy.
- Figure 4 shows the results of assays measuring Xanthomonas resistance in transgenic plants comprising the Xa21 gene from the pB822 clone.
- Figure 5 shows the map position of TRK1.
- Figure 6 shows the map position of TRL1.
- This invention relates to plant RRK genes, such as the Xa21 genes of rice.
- Nucleic acid sequences from RRK genes, in particular Xa21 genes, can be used to confer resistance to Xanthomonas and other pathogens in plants.
- the invention has use in conferring resistance in all higher plants susceptible to pathogen infection.
- the invention thus has use over a broad range of types of plants, including species from the genera Juglans, Fragaria, Lotus, Medicago, Onobrychis, Trifolium, Trigonella, Vigna, Citrus, Linum, Geranium, Manihot, Daucus, Arabidopsis, Brassica, Raphanus, Sinapis, Atropa, Capsicum, Datura, Hyoscyamus, Lycopersicon, Nicotiana, Solanum, Petunia, Digitalis, Majorana, Ciahorium, Helianthus, Lactuca, Bromus, Asparagus, Antirrhinum,
- Heterocallis Nemesis, Pelargonium, Panieum, Pennisetum, Ranunculus, Senecio, Salpiglossis, Cucumis, Browaalia, Glycine, Pisum, Phaseolus, Lolium, Zea, Avena, Hordeum, Secale, Triticum, and, Sorghum.
- Example section below which describes the isolation and characterization of Xa21 genes in rice, is exemplary of a general approach for isolating Xa21 genes and other RRK genes.
- the isolated genes can then be used to construct recombinant vectors for transferring RRK gene expression to transgenic plants.
- DNA technology described below are those well known and commonly employed in the art. Standard techniques are used for cloning, DNA and RNA isolation, amplification and purification. Generally enzymatic reactions involving DNA ligase, DNA
- oligonucleotide probes based on the sequences disclosed here can be used to identify the desired gene in a cDNA or genomic DNA library.
- genomic libraries large segments of genomic DNA are generated by random fragmentation, e.g. using restriction endonucleases, and are ligated with vector DNA to form concatemers that can be packaged into the appropriate vector.
- cDNA library mRNA is isolated from the desired organ, such as leaf and a cDNA library which contains the RRK gene transcript is prepared from the mRNA.
- cDNA may be prepared from mRNA extracted from other tissues in which RRK genes or homologs are expressed.
- the cDNA or genomic library can then be screened using a probe based upon the sequence of a cloned RRK gene such as rice Xa21 genes disclosed here. Probes may be used to hybridize with genomic DNA or cDNA sequences to isolate homologous genes in the same or different plant species.
- the nucleic acids of interest can be amplified from nucleic acid samples using amplification techniques. For instance, polymerase chain reaction (PCR) technology to amplify the sequences of the RRK and related genes directly from genomic DNA, from cDNA, from genomic libraries or cDNA libraries. PCR and other in vitro amplification methods may also be useful, for example, to clone nucleic acid sequences that code for proteins to be expressed, to make nucleic acids to use as probes for detecting the presence of the desired mRNA in samples, for nucleic acid sequencing, or for other purposes.
- PCR polymerase chain reaction
- PCR Protocols A Guide to Methods and Applications. (Innis, M, Gelfand, D., Sninsky, J. and White, T., eds.), Academic Press, San Diego (1990), incorporated herein by reference.
- Polynucleotides may also be synthesized by well-known techniques as described in the technical literature. See, e.g., Carruthers et al. , Cold Spring Harbor Symp. Quant. Biol. 47:411-418 (1982), and Adams et al. , J. Am. Chem. Soc. 105:661 (1983). Double stranded DNA fragments may then be obtained either by synthesizing the complementary strand and annealing the strands together under appropriate conditions, or by adding the complementary strand using DNA polymerase with an appropriate primer sequence.
- Isolated sequences prepared as described herein can then be used to provide RRK gene expression and therefore Xanthomonas resistance in desired plants.
- nucleic acid encoding a functional RRK protein need not have a sequence identical to the exemplified gene disclosed here.
- polypeptides encoded by the RRK genes like other proteins, have different domains which perform different functions.
- the RRK gene sequences need not be full length, so long as the desired functional domain of the protein is expressed.
- the proteins of the invention comprise an extracellular leucine rich repeat domain, as well as an intracellular kinase domain.
- Modified protein chains can also be readily designed utilizing various recombinant DNA techniques well known to those skilled in the art.
- the chains can vary from the naturally occurring sequence at the primary structure level by amino acid
- Modification can also include swapping domains from the proteins of the invention with related domains from other pest resistance genes.
- the extra cellular domain (including the leucine rich repeat region) of the proteins of the invention can be replaced by that of the tomato Cf-9 gene and thus provide resistance to fungal pathogens of rice.
- a DNA sequence coding for the desired RRK polypeptide will be used to construct a recombinant expression cassette which can be introduced into the desired plant.
- An expression cassette will typically comprise the RRK polynucleotide operably linked to transcriptional and translational initiation regulatory sequences which will direct the transcription of the sequence from the RRK gene in the intended tissues of the
- a plant promoter fragment may be employed which will direct expression of the RRK in all tissues of a regenerated plant.
- Such promoters are referred to herein as "constitutive" promoters and are active under most environmental conditions and states of development or cell differentiation.
- constitutive promoters include the cauliflower mosaic virus (CaMV) 35S transcription initiation region, the 1'- or 2'- promoter derived from T-DNA of Agrobacterium tumafaciens, and other transcription initiation regions from various plant genes known to those of skill.
- the plant promoter may direct expression of the RRK gene in a specific tissue or may be otherwise under more precise environmental or developmental control. Such promoters are referred to here as "inducible" promoters. Examples of environmental conditions that may effect transcription by inducible promoters include pathogen attack, anaerobic conditions, or the presence of light.
- promoters under developmental control include promoters that initiate transcription only in certain tissues, such as leaves, roots, fruit, seeds, or flowers.
- the operation of a promoter may also vary depending on its location in the genome. Thus, an inducible promoter may become fully or partially constitutive in certain locations.
- the endogenous promoters from the RRK genes of the invention can be used to direct expression of the genes. These promoters can also be used to direct expression of heterologous structural genes. Thus, the promoters can be used in recombinant expression cassettes to drive expression of genes conferring resistance to any number of pathogens, including fungi, bacteria, and the like.
- promoter sequence elements include the TATA box consensus sequence (TATAAT), which is usually 20 to 30 base pairs upstream of the transcription start site.
- TATAAT TATA box consensus sequence
- promoter element with a series of adenines surrounding the trinucleotide G (or T) N G.
- a polyadenylation region at the 3'-end of the RRK coding region should be included.
- the polyadenylation region can be derived from the natural gene, from a variety of other plant genes, or from T-DNA.
- the vector comprising the sequences from an RRK gene will typically comprise a marker gene which confers a selectable phenotype on plant cells.
- the marker may encode biocide resistance, particularly antibiotic resistance, such as resistance to kanamycin, G418, bleomycin, hygromycin, or herbicide resistance, such as resistance to chlorosluforon or Basta.
- DNA constructs may be introduced into the genome of the desired plant host by a variety of conventional techniques.
- the DNA construct may be introduced directly into the genomic DNA of the plant cell using techniques such as electroporation, PEG poration, particle bombardment and microinjection of plant cell protoplasts or embryogenic callus, or the DNA constructs can be introduced directly to plant tissue using ballistic methods, such as DNA particle bombardment.
- the DNA constructs may be combined with suitable T-DNA flanking regions and introduced into a conventional Agrobacterium tumefaciens host vector. The virulence functions of the Agrobacterium tumefaciens host will direct the insertion of the construct and adjacent marker into the plant cell DNA when the cell is infected by the bacteria.
- Transformation techniques are known in the art and well described in the scientific and patent literature. The introduction of DNA constructs using polyethylene glycol precipitation is described in Paszkowski et al. Embo J. 3:2717-2722 (1984).
- Electroporation techniques are described in Fromm et al. Proc. Natl. Acad. Sci. USA 82:5824 (1985). Ballistic transformation techniques are described in Klein et al. Nature 327:70-73 (1987). Using a number of approaches, cereal species such as rye (de la Pena et al. , Nature 325:274-276 (1987)), corn (Rhodes et al. , Science 240:204-207 (1988)), and rice (Shimamoto et al. , Nature 338:274-276 (1989) by electroporation; Li et al. Plant Cell Rep. 12:250-255 (1993) by ballistic techniques) can be transformed.
- Agrobacterium tumefaciens-meditated transformation techniques are well described in the scientific literature. See, for example Horsch et al. Science 233:496-498 (1984), and Fraley et al. Proc. Natl. Acad. Sci. USA 80:4803 (1983).
- Agrobacterium is useful primarily in dicots, certain monocots can be transformed by
- Agrobacterium transformation of rice is described by Hiei et al, Plant J. 6:271-282 (1994).
- Transformed plant cells which are derived by any of the above transformation techniques can be cultured to regenerate a whole plant which possesses the transformed genotype and thus the desired RRK-controlled phenotype.
- Such regeneration techniques rely on manipulation of certain phytohormones in a tissue culture growth medium, typically relying on a biocide and/or herbicide marker which has been introduced together with the RRK nucleotide sequences. Plant regeneration from cultured protoplasts is described in Evans et al. , Protoplasts Isolation and Culture, Handbook of Plant Cell Culture, pp. 124-176, MacMillilan Publishing Company, New York, 1983; and Binding, Regeneration of Plants, Plant Protoplasts, pp.
- Regeneration can also be obtained from plant callus, explants, organs, or parts thereof. Such regeneration techniques are described generally in Klee et al. Ann. Rev. of Plant Phys. 38:467-486 (1987).
- the methods of the present invention are particularly useful for
- the RRK polypeptides may be expressed at times or in quantities which are not characteristic of natural plants.
- the expression cassette is stably incorporated in transgenic plants and confirmed to be operable, it can be introduced into other plants by sexual crossing. Any of a number of standard breeding techniques can be used, depending upon the species to be crossed.
- the effect of the modification of RRK gene expression can be measured by detection of increases or decreases in mRNA levels using, for instance, Northern blots.
- the phenotypic effects of gene expression can be detected by measuring lesion length as in plants. Suitable assays for determining resistance are described below.
- Plant genes may also be isolated using map-based cloning methods. This strategy consists of identifying DNA markers that are tightly linked to the gene or genes of interest.
- map-based cloning and physical analysis of large chromosomal regions is the availability of libraries containing large inserts of genomic DNA.
- Shizuya, H., et al. Proc. Natl. Acad. Sci. 89, 8794-8797 (1992)
- BAC bacterial artificial chromosome
- This system utilizes an F-factor-based vector and is capable of maintaining human genomic DNA fragments of >300 kb. DNA can be cloned with high efficiency, manipulated easily and stably maintained in E. coli. The following is a description of the use of this technique to isolate genes of the invention.
- IRRI International Rice Research Institute
- IR-BB21 carrying Xa-21 was used as the plant material.
- the plants were grown in the greenhouse for 3-5 weeks.
- Leaf tissue was harvested and washed with distilled water before grinding.
- High molecular weight DNA was extracted from rice tissue essentially as described by Hatano, S., et al., Plant Sciences, 83, 55-64, (1992) and Zhang, H.B., et al., Plant J. 7:175-184 (1994), with the following modifications: approximately 20 grams of leaf tissue was ground into powder using a cold mortar and pestle in liquid nitrogen.
- the powder was suspended by stirring in 200 ml cold nuclei-extraction (NE) buffer (1 MM spermidine, 1 mM spermine, 10 mM Na 2 EDTA, 10 mm Trizma base, 80 mM KCI, 0.5% Triton-X 100 and 0.4 M sucrose, pH 9.4).
- NE cold nuclei-extraction
- the mixture was filtered through two layers of cheesecloth into a GSA bottle and centrifuged at 1200 g at 4°C for 20 min. The supernatant was poured off and the nuclear pellet (pale green) was resuspended in 50 ml cold NE Buffer.
- the resuspended pellet was then filtered through an 80-micron sieve into a 50 ml tube to remove green tissue debris and then centrifuged at 1000 g for 10 min. The pellet was resuspended and centrifuged as above without passing through the 80-micron sieves.
- the nuclear pellet (about 5 ⁇ 10 8 nuclei/ml) was resuspended in 2.5 ml of SCE buffer (1M sorbitol, 0.1M NaCitrate, 60 mM EDTA, pH 7.0) and embedded in 2.5 ml 1 % low-melting-point (LMP) agarose (Ultrapure).
- 80 ⁇ l plugs were incubated in 25 ml ESP solution (0.5M EDTA, pH 9.3, 1 % sodium laurel sarcosine, 5 mg/ml proteinase K, Boehringer Mannheim) at 50°C for two days with one change of the buffer. Each plug contained about 5 ⁇ g DNA.
- ESP solution 0.5M EDTA, pH 9.3, 1 % sodium laurel sarcosine, 5 mg/ml proteinase K, Boehringer Mannheim
- Agarose plugs were dialyzed twice against TE (10 mm Tris-HCI and 1 mM EDTA, pH 8.0) plus 1 mm PMSF (phenylmethyl sulphonyl fluoride) at 50°C for one h, and then equilibrated with Hindin buffer (50 mM NaCl, 10 mM Tris-HCl, 10 mM MgCl 2 and 1 mM dithiothreitol, pH 7.9) twice at room temperature for one hr. Plugs were melted at 65°C for 15 min and kept at 37°C for 5 min before partial digestion. Five to seven units of HindIII (NEB, USA) per plug were added to the DNA solution and incubated at 37°C for 30 min.
- TE 10 mm Tris-HCI and 1 mM EDTA, pH 8.0
- PMSF phenylmethyl sulphonyl fluoride
- the reaction was stopped by addition of 1/10 volume of 0.5 M EDTA, pH 8.0.
- Partially digested DNA was immediately loaded into a 0.8% LMP agarose gel with a pipette tip cut off to an inside diameter of 2 mm and separated by PFGE (CHEF DR II system, BioRad, USA).
- PFGE CHEF DR II system, BioRad, USA.
- Two different PFGE methods were used for the library construction. Firstly, the gel was subjected to electrophoresis at 15OV, using an 8 s initial and 8 s final switch time for 16 h at 14°C.
- the unresolved DNA ( ⁇ 200 kb) was focused into a thin band.
- the gel was subject to electrophoresis at 150V, ramped switching time from 60 to 90 s for 16 h at 14°C.
- the gel containing the partially digested DNA was cut and soaked in TE while the marker lanes of the gel were stained with ethidium bromide.
- the agarose slice containing fragments larger than 200 kb (the first PFGE method) or agarose slice containing 250-350 kb (the second method) was excised from the gel.
- the agarose slice was equilibrated in TE for 2 h at 4°C, placed in a 1.5 ml tube, melted at 65°C for 10 min, digested with Gelase (Epicentre, USA) (one unit of enzyme per 100 mg agarose) and incubated at 45°C for one hr.
- the DNA solution was directly used for the ligation reaction.
- the vector, pBeloBAC II was provided by Drs. H. Shizuya and M.
- This vector contains the lacz gene inserted into the vector pBAC108L. Shizuya, et al. (1992). A single colony was inoculated into 5 ml LB media containing 12.5 ⁇ g/ml chloramphenicol and grown at 37°C for 4-5 h before adding to 6 liters of LB media. The inoculum was grown for about 16 h at 37°C to an OD 600nm 1.3-1.5. The plasmid was isolated using Qiagen's plasmid maxi isolation kit (Qiagen, USA). Vector DNA was further purified by cesium chloride/ethidium bromide equilibrium centrifugation at 45,000 RPM for 60 h.
- the rotor was decelerated to 35,000 RPM for one hr. to allow the gradient to relax, using a fixed anger rotor 70.1 (Beckman, USA).
- the plasmid was digested with HindIII to completion and assayed by gel electrophoresis.
- Vector ends were dephosphorylated with HK phosphatase (Epicenter, USA) at 30°C for one hr., using 1 unit of the enzyme per 1 ⁇ g of vector ]DNA.
- the HK phosphatase was inactivated by heating at 65°C for 30 min.
- the ligation was carried out in a 100 ⁇ l volume in which about 40 ng of the
- size-selected rice DNA (about 85 ⁇ l) was ligated to 10 ng of HindIII-digested vector (1 ⁇ l) molar ratio of about 10 to 1 in vector excess) with 400 units of T4 DNA ligase (NEB, USA) at 16°C overnight. Before transformation, the litigation was dialyzed against TE in an ULTRAFREE-MC filter tube (Millipore, USA) at 4°C overnight.
- Transformation of competent E. coli D ⁇ 10B cells was carried out by electroporation using a Cell-Porator (GIBCO-BRL, USA) at the following settings: voltage: 400; charge rate: fast; voltage booster resistance: 4,000; capacitance: 330 ⁇ ; impedance: low. Thirteen ⁇ l of competent cells were mixed with 0.5-1.0 ⁇ l of ligation solution for each electroporation.
- cells were transferred to 1 ml SOC solution (2% Bacto tryptone, 0.5% Bacto yeast extract, 10 MM NaCl, 2.5 mM KCI, 10 mM MgCl 2 , 10 mM MgSO 4 , 20 mM Glucose, pH 7.0) and incubated at 37°C with gentle shaking (90-95 RPM,) for 45 min.
- SOC solution 2% Bacto tryptone, 0.5% Bacto yeast extract, 10 MM NaCl, 2.5 mM KCI, 10 mM MgCl 2 , 10 mM MgSO 4 , 20 mM Glucose, pH 7.0
- the cells were spread on LB plates containing chloramphenicol (12.5 ⁇ g/ml), X-gal (40 ⁇ g/ml) and IPTG
- the BAC clones were transferred to 384-well microtiter plates (Genetix, UK) containing 60 ⁇ l of LB freezing buffer (36 mM K 2 HPO 4 , 13.2 mM KH 2 PO 4 , 1.7 mM Citrate, 0.4 MM MgSO 4 , 6.8 mM (NH 4 ) 2 SO 4 , 4.4% v/v Glycerol, 12.5 ⁇ g/ml chloramphenicol, LB) and incubated at 37oC for 24 h. Since more than 95% of the colonies were still white on the second screen, only one screen was used in the subsequent experiments, and white colonies were directly picked to 384-well microtiter plates. The library was replicated in duplicate and stored in two different -80°C freezers.
- the BAC clones in each 384-well microtiter plate were replicated onto a Hybond N + filter (Amersham, USA).
- the filter was put into a plastic box containing LB/agar with 12.5 ⁇ g/ml chloramphenicol and the box was kept at 37°C overnight until the colonies were about 2-3 mm in diameter.
- Treatment of the filters was as described. Nizetic, D., et al., Nucl. Acids Res. 19, 182 (1990); Hoheisel, J.D., et al, Cell, 73, 109-120 (1993). Hybridization and washing conditions were the same as described in Hoheisel, et al. (1993). Probes were labeled using random primer extension. Feinberg, A.P. and Vogelstein, B., Anal. Biochem. 132, 6-13 (1983); Addendum 137, 266-267 (1984).
- the BAC library described above of consists of 11,000 clones.
- the library was constructed using two different approaches. A first half of the library having 7269 BAC clones was made with one size selection using a compression zone method as described in Ramsay, M. and Wicking, C., Protocols in Human Molecular Genetics, 197-221 (1991). A second half of the library having 3731 clones was made using double size-selection of partially digested DNA. Double size-selection failed, however, to increase the average DNA insert size. Apparently, there were small DNA molecules still present in the size-selected DNA solution (only 250-350 kb DNA isolated).
- High molecular weight DNA used to construct the BAC library was isolated from purified rice nuclei. Most of the chloroplasts and mitochondria were removed by low speed centrifugation ( ⁇ 1000 g). The low frequency of chloroplast or mitochondrial clones found in the inventive BAC library ( ⁇ O.3%) reduces the possibility of organellar/nuclear DNA co-ligation.
- the BAC library was used to construct a contiguous set of clones (contig) spanning the Xa21 locus.
- RAPD818 in Ronald, et al. were used to screen the BAC library.
- RG103 is found in 8 copies in the Xa21-containing line and hybridizes with 8 genomic HindIII DNA fragments in this line. All of these fragments are genetically and physically linked to the Xa21 disease resistance locus.
- pTA818 hybridizes with 2 DNA fragments and at least one of these fragments is linked to the Xa21 locus.
- the pTA818 sequences and four (out of eight) of the RG103 hybridizing sequences are over represented in this portion of the library.
- the other four RG103 hybridizing sequences are under represented.
- the DNA insert sizes of these clones ranged from 40 to 140 kb.
- the rice line, 1188 carrying the Xa-21 locus was used as the plant material for isolation of HMW DNA.
- 120 g 4-6 weeks old leaf tissue was harvested and ground into fine powder using a cold mortar and pestle in liquid nitrogen.
- the powder was then suspended by stirring in 800 ml cold H buffer [4 mM spermidine, 1 mM spermine, 10 mM EDTA, 10 mM Tris-HCl, 80 mM KCl, 0.5 M sucrose, 1mM PMSF (phenylmethyl sulphony fluoride, add just before use), 0.5% (v/v) Triton-X 100, 1/1000 (v/v) ⁇ -mercaptoethanol (add just before use), pH 9.5].
- 800 ml cold H buffer [4 mM spermidine, 1 mM spermine, 10 mM EDTA, 10 mM Tris-HCl, 80 mM KCl, 0.5 M sucrose, 1mM PMSF (pheny
- the mixture was filtered through an 80-micron sieve into GSA bottles and the pellet resuspended in 400 ml H buffer and filtered again. The two filtrate volumes were combined and centrifuged at 3500 rpm for 10 min at 4°C. The pellet was resuspended in 300 ml washing buffer (same as H buffer except PMSF and ⁇ -mercaptoethanol) and centrifuged at 3500 rpm for 10 min at 4°C. The pellet was washed two additional times until the color of the pellet was pale green.
- the pellet was resuspended in 40 ml washing solution and the nuclei were lysed by adding an equal volume of lysis buffer ( 2% Na laurel sarcosine, 100 mM Tris-HCl, 0.5 M EDTA, pH 9.5) containing 2 mg/ml proteinase K (Boehringer Mannheim). Proteins were removed by incubation at 50°C for 5 hr and then extraction of the solution (by gentle inversion) with an equal volume of phenol-chloroform-isoamyl alcohol (24:24:1) for 30 min at room temperature. The HMW DNA was precipitated by gently layering 1/10 vol. of 3M sodium acetate (pH 5.5), 2 vol. of ethanol and inverting several times.
- lysis buffer 2% Na laurel sarcosine, 100 mM Tris-HCl, 0.5 M EDTA, pH 9.5
- proteinase K Boehringer Mannheim
- the DNA was removed from the ethanol using wide-mouth pipette tips, washed with 70% ethanol, dried and dissolved into 1 ml of TE (10 mM Tris-HCl, 1mM EDTA, pH8.0) at 4°C overnight without shaking. Normally, 250 ug HMW DNA can be isolated from 120 g leaves.
- the partially digested DNA was fractionated on a sucrose density gradient of 5 to 40% by centrifuge in an SW27 rotor at 26,000 rpm at 20°C for 13 hr. 0.8 ml fractions (20 total) were collected by carefully placing a capillary tube at the bottom of the centrifuge tube and pumping out the gradient at a very slow speed. 20 ul of each samples was assayed on a 0.3% agarose gel at 2 V/cm gel length for 36 hr. DNA fractions with approximately 35-50 kb were pooled together. After diluting the sucrose with an equal vol. of H2O, the DNA was precipitated with 2 vol. ethanol. The partial fill in reaction was achieved using standard protocols.
- the cosmid vector, pHC80 was kindly provided by Dr. Scot Hulbert.
- Vector and insert DNA were ligated in a 2 to 1 molar ratio, at a final concentration of 0.8 ug/ul.
- the ligation reaction was carried out with 600 units of T4 DNA ligase (NEB, USA) at 16°C for overnight.
- the ligated DNA was in vitro packaged with GigapackII packaging extract (Stratagene, USA) and transfected into competent cell, E.coli NM554, according to the Stratagene manual.
- 61440 cosmid colonies (more than five genome equivalents) in 160 384-well microtiter plates were transferred onto Hybond N+ filters (Amersham, USA) in two type densities.
- the cosmid clones were replicated in low density (1536 colonies/11.5x15 cm filter) using manual replicators (Genetix, U.K.) and grown on LB/agar with 100 ug/ml ampicillin for overnight. Forty filters were made to cover the whole cosmid library.
- the cosmid clones were replicated in high density arrays using a Beckman BiomekTM robotic workstation and grown using the same method as above. Using 3 ⁇ 3 arrays, 3456 colonies were transferred onto an 8.5 ⁇ 12cm filter.
- a reference cosmid colony (containing the RG103 marker) was plated in the first position of each 3 ⁇ 3 grid. The remaining eight offset position were plated with colonies from eight microtiter plates of the cosmid library. In this case, 20 filters in size of 8.5 ⁇ 12 cm each can cover the whole library.
- the RG103 probe was mixed with the unique probe in a ratio of 1:4 to produce the reference pattern.
- Bacteria on the filters were lysed and fixed using the steaming water bath procedure with the following modification: colonies were placed face up on top of two pieces of 3 MM Whatman soaked in lysis solution (0.5 M NaOH, 1.5 M NaCl) for 4 min at room temperature, the plastic boxes containing the filters were incubated in a steaming water bath at 85 °C for 6 min and then the filters were transferred to 3 MM Whatman soaked in neutralization buffer (1 M Tris-HCl (pH7.4), 1.5 M NaCl) for 4 min. Proteins and cell debris were removed by submergence in 50 ml proteinase K solution (50 mM
- Tris-HCl pH8.5
- 50 mM EDTA pH8.0
- 100 mM NaCl 1 % (w/v)
- Hybridization was performed according to standard procedures as follows: filters were subjected to prehybridization solution (7% SDS, 0.5 M Na 2 PO 4 (pH 7.2), 1 mM EDTA, 100 ug/ml ssDNA) at 65°C for 2 hr to overnight. Probes were labeled using the random primer extension procedure and hybridization was performed at 65 °C with shaking overnight. The filters were washed briefly in (40 mM Na 2 PO 4 (pH 7.2), 0.1 % SDS) at room temperature and the filters were incubated in the same solution at 65 °C for 20 min with gentle shaking. B. RESULTS
- RG103 Three Xa21-linked markers (RG103, RAPD 248 and RAPD 818) were used to screen the cosmid library. Genomic Southern analysis showed that the copy numbers of these three markers in resistant lines are 8, 1 and 2 respectively (unpublished results). Six positive cosmid clones hybridizing with the RG103 marker were identified and confirmed by further Southern analysis. However, no positive clones were identified to contain RAPD248 and RAPD818.
- Figures 2A-2E are partial restriction maps of the cosmid clones.
- Figure 2F is a partial restriction map of the BAC clone.
- SEQ. ID. No. 1 It includes the promoter region, the predicted intron and a partial 3' sequence.
- SEQ. ID. No. 2 shows the predicted amino acid sequence. The predicted intron has been spliced out.
- the predicted amino acid sequence has revealed two features of the protein which indicate it is encoded by a member of the new class of plant disease resistance genes referred to here as RRK genes.
- the extracellular domain of the proteins encoded by these genes comprise a block of about 23 tandem leucine-rich repeats (LRR) with an average length of 24 amino acids.
- LRR motif has been implicated in protein-protein interactions and ligand binding in a variety of proteins.
- the extracellular domain also comprises a region between the LRRs and the signal peptide which contain a motif, SWNTS, which is conserved among a number of proteins, including, Cf-9, PGIP, and RLK5.
- the protein comprises a region with high sequence identity to receptor-like protein kinases (RLPKs) such as RLK5 and TMK1 (Walker et al. Plant J. 3:451 (1993); Chang et al. Plant Cell 4: 1263 (1992); Valon et al. Plant Molec. Biol. 23:415 (1993)) as well as the tomato resistance gene product, Pto (Martin et al. Science 262: 1432 (1993).
- the signal domain, the extracellular domain (including the LRR region), the transmembrane domain and the cytoplasmic kinase domain are identified in SEQ. ID. No. 2.
- Figure 3 is a restriction map of a second clone, pB822, which was used to construct the plasmid used in the transformation experiments described in Example 3, below.
- the Xa21 gene in this clone has also been sequenced (SEQ. ID. No. 3).
- the predicted amino acid sequence revealed the same motifs identified in SEQ. ID. No. 2.
- the protein kinase domain carries 11 subdomains containing 15 conserved residues diagnostic of protein kinases and is flanked by a 31 aa juxtamembrane domain (aa 677-707) and a C terminus domain.
- the presumed intron is located between the two highly conserved residues P and E (aa 892 and aa 893) in the putative catalytic domain.
- KID kinase interacting domain
- Arabidopsis KID is functionally analogous to the SH2 domain of animal proteins.
- this region act as a high affinity and specific binding site for proteins containing KID. Modification of the amino acid sequence of this region of Xa21 can thus be used to alter affinity for the KID protein and thus control intracellular signalling in response to ligand binding of the LRR domain.
- the Xa21 gene described above was used to transform rice plants to demonstrate that the genes could confer Xanthomonas resistance to susceptible plants.
- the gene was introduced into susceptible rice strains using a variation of the methods of Li et al , Plant Cell Rep. 12:250-255 (1993). Briefly, co-transformation was carried out using the hygromycin construct pMON410 (from Monsanto) and a bluescript vector containing the sequences of interest.
- the Kpn fragment of pB822 was cloned into the pTA818 vector, which is derived from Invitrogen vector per 1000 and contains the 1kb fragment RAPD818 (Ronald et al , supra). The resulting plasmid is referred to as pC822.
- the plants were selected on hygromycin (30mg/L) and then screened for resistance to Xoo race 6.
- Standard methods were used to test Xanthomonas resistance in the transformants.
- the assays were carried out according to the methods of Kaufman et al Plant Disease Rep. 57:537-541 (1973). Briefly, Xoo race 6 was grown on PSA plates for 3 days. The bacteria were scraped up, resuspended in water and the OD adjusted to 10 9 colony forming units per ml. Scissors were dipped in the suspension and leaves from the transformed plants (4 months post bombardment) were cut 5 cm from the tip.
- Plants were scored for the presence of lesions 11 days post inoculation.
- Figure 4 shows lesion length data from experiments using an expression vector comprising the gene from the pC822 clone.
- Individuals derived from independent transformants 106, -9, -22, -11, -17, -1, -12, -4, 16, and -29 carry the pC822 construct and showed increased resistance as compared to susceptible untransformed controls (IR24), as well as rice plants transformed with the vector (1-15).
- Xa21 sequence can be used to isolate RRK genes from other plant species using a degenerate primer or low stringency hybridization approach.
- This example describes the isolation and characterization of two RRK genes from tomato using a degenerate primer approach.
- PCR polymerase Chain Reaction
- the forward primers were taken from motifs conserved in the LRR region of Xa21 and several other plant proteins (e.g. , Cf-9, RLK5, and PG1P).
- the reverse primers were taken from motifs conserved in the Xa21 kinase domain and other plant serine-threonine kinase domains( e.g., RLK5, Pto, and Fen (Martin et al. Plant Cell 6: 1543-1552 (1994)).
- the degenerate primers used for amplification of PCR products were as follows:
- the PCR conditions were as follows (20 micro liter reaction): First cycle:
- the annealing temperature dropped down 1C every cycle. After the 20 cycles are finished, the reaction was incubated for 10 min at 72C .
- the PCR products were cloned and used as probes to a tomato cDNA library.
- the library was constructed from tomato cDNA thatwas primed with oligo DT primers, ligated to EcoRI adaptors and cloned into a lambda GT11 vector.
- TRKl Tomato Receptor Kinase 1
- TRKl is shown in SEQ. ID. No. 12.
- This clone is present as one or two copies in the tomato genome and onecopy maps to the short arm of chromosome 1 in the proximity of a resistance gene to
- the second clone TRLl (Tomato Receptor Like 1) is a 496bp
- TRLl maps within a few cM of men (see, Figure 6) a mutation on chromosome 3 that causes spotty necrosis on plants, typical of a defense phenotype.
- TRK1 and TRL1 genes that were isolated are important components of plant signal transduction pathways leading to a defense response. These genes are useful to engineer disease resistance in tomato and other plant species.
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Botany (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU48997/96A AU710145B2 (en) | 1995-01-17 | 1996-01-17 | Procedures and materials for conferring disease resistance in plants |
BR9606918A BR9606918A (pt) | 1995-01-17 | 1996-01-17 | Procedimentos e materiais para conferir resistência a doenças em plantas |
EP96905167A EP0805860A2 (fr) | 1995-01-17 | 1996-01-17 | Procedures et materiaux destines a conferer a des plantes la resistance a des maladies |
JP8522397A JPH11514206A (ja) | 1995-01-17 | 1996-01-17 | 植物における病気耐性付与のための手順及び材料 |
MX9705580A MX9705580A (es) | 1995-01-17 | 1996-01-17 | Procedimientos y materiales para conferir resistencia a la enfermedad en las plantas. |
NZ302843A NZ302843A (en) | 1995-01-17 | 1996-01-17 | A nucleic acid from a RRK gene such as Xa21 which confers resistance to Xanthomonas in a plant |
PL96321365A PL185422B1 (pl) | 1995-01-17 | 1996-01-17 | Procedury i materiały nadające roślinom odporność na choroby |
FI972986A FI972986A0 (fi) | 1995-01-17 | 1997-07-14 | Foerfaranden och material som foerlaenar vaexter sjukdomsresistens |
BG101832A BG62976B1 (bg) | 1995-01-17 | 1997-08-14 | Методи и материали за придаване на устойчивост на растенията към болести |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37337595A | 1995-01-17 | 1995-01-17 | |
US08/373,374 | 1995-01-17 | ||
US08/475,891 | 1995-06-07 | ||
US08/475,891 US5859339A (en) | 1995-01-17 | 1995-06-07 | Nucleic acids, from oryza sativa, which encode leucine-rich repeat polypeptides and enhance xanthomonas resistance in plants |
US464595P | 1995-09-29 | 1995-09-29 | |
US06/004,645 | 1995-09-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1996022375A2 true WO1996022375A2 (fr) | 1996-07-25 |
WO1996022375A3 WO1996022375A3 (fr) | 1996-10-17 |
Family
ID=45476045
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1996/000717 WO1996022375A2 (fr) | 1995-01-17 | 1996-01-17 | Procedures et materiaux destines a conferer a des plantes la resistance a des maladies |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0805860A2 (fr) |
JP (1) | JPH11514206A (fr) |
CN (1) | CN1114694C (fr) |
AU (1) | AU710145B2 (fr) |
BG (1) | BG62976B1 (fr) |
BR (1) | BR9606918A (fr) |
CA (1) | CA2210440A1 (fr) |
GE (1) | GEP20022684B (fr) |
HU (1) | HUP9802411A3 (fr) |
MX (1) | MX9705580A (fr) |
NZ (1) | NZ302843A (fr) |
PL (1) | PL185422B1 (fr) |
TR (1) | TR199700650T1 (fr) |
WO (1) | WO1996022375A2 (fr) |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999009151A3 (fr) * | 1997-08-13 | 1999-08-05 | Univ California | Procedes et materiaux destines a conferer aux plantes une resistance aux maladies |
WO1999043821A1 (fr) * | 1998-02-26 | 1999-09-02 | Pioneer Hi-Bred International, Inc. | Genes activant le systeme de defense de plantes contre les elements pathogenes |
WO1999043823A1 (fr) * | 1998-02-26 | 1999-09-02 | Pioneer Hi-Bred International, Inc. | Genes activant le systeme de defense de plantes contre les elements pathogenes |
WO1999045129A1 (fr) * | 1998-03-06 | 1999-09-10 | Mogen International N.V. | Procede induisant une resistance aux pathogenes dans les plantes |
WO1999064600A1 (fr) * | 1998-06-08 | 1999-12-16 | Istituto Agrario Di San Michele All'adige | SEQUENCES DE NUCLEOTIDES DU GENE LRPKm1 DE LA POMME, SEQUENCES AMINOACIDES CODEES ET LEURS MISES EN APPLICATION |
WO2000004155A3 (fr) * | 1998-07-17 | 2000-04-20 | Purdue Research Foundation | Compositions et procedes servant a augmenter la resistance de plantes a des maladies |
WO2000009698A3 (fr) * | 1998-08-14 | 2000-07-06 | Univ Kansas State | Composes s'utilisant pour rendre des plantes resistantes et procedes afferents |
WO2002010367A1 (fr) * | 2000-07-28 | 2002-02-07 | The Salk Institute For Biological Studies | Recepteurs chimeres et leurs utilisations |
US6476292B1 (en) | 1998-02-26 | 2002-11-05 | Pioneer Hi-Bred International, Inc. | Methods for enhancing disease resistance in plants |
WO2010046423A2 (fr) | 2008-10-22 | 2010-04-29 | Basf Se | Utilisation d'herbicides sulfonylurées sur des plantes cultivées |
WO2010046422A2 (fr) | 2008-10-22 | 2010-04-29 | Basf Se | Utilisation d'herbicides de type auxine sur des plantes cultivées |
WO2014053395A1 (fr) | 2012-10-01 | 2014-04-10 | Basf Se | Utilisation de composés de n-thio-anthranilamide sur des plantes cultivées |
WO2014079820A1 (fr) | 2012-11-22 | 2014-05-30 | Basf Se | Utilisation de composés d'anthranilamides pour réduire les infections virales véhiculées par les insectes |
EP3028573A1 (fr) | 2014-12-05 | 2016-06-08 | Basf Se | Utilisation d'un triazole fongicide sur des plantes transgéniques |
WO2016091674A1 (fr) | 2014-12-12 | 2016-06-16 | Basf Se | Utilisation de cyclaniliprole sur des plantes cultivées |
WO2016162371A1 (fr) | 2015-04-07 | 2016-10-13 | Basf Agrochemical Products B.V. | Utilisation d'un composé de carboxamide insecticide contre les nuisibles sur des plantes cultivées |
EP3338552A1 (fr) | 2016-12-21 | 2018-06-27 | Basf Se | Utilisation d'un fongicide tetrazolinone sur des plantes transgéniques |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1114616C (zh) * | 1999-08-10 | 2003-07-16 | 南京农业大学 | 一种诱导植物过敏性反应的激发子、制备方法及其应用 |
CN102134602B (zh) * | 2010-12-21 | 2013-04-24 | 中国检验检疫科学研究院 | 转Xa21基因水稻或其制品检测用引物和探针、试剂盒及方法 |
CN114941008B (zh) * | 2022-05-25 | 2023-03-24 | 广东省农业科学院设施农业研究所 | 菜心LRR受体蛋白激酶基因BraEFR在抗霜霉病中的应用 |
-
1996
- 1996-01-17 WO PCT/US1996/000717 patent/WO1996022375A2/fr not_active Application Discontinuation
- 1996-01-17 TR TR97/00650T patent/TR199700650T1/xx unknown
- 1996-01-17 AU AU48997/96A patent/AU710145B2/en not_active Ceased
- 1996-01-17 BR BR9606918A patent/BR9606918A/pt not_active Application Discontinuation
- 1996-01-17 CN CN96191493A patent/CN1114694C/zh not_active Expired - Fee Related
- 1996-01-17 HU HU9802411A patent/HUP9802411A3/hu unknown
- 1996-01-17 MX MX9705580A patent/MX9705580A/es not_active IP Right Cessation
- 1996-01-17 CA CA002210440A patent/CA2210440A1/fr not_active Abandoned
- 1996-01-17 GE GE2791A patent/GEP20022684B/en unknown
- 1996-01-17 JP JP8522397A patent/JPH11514206A/ja not_active Withdrawn
- 1996-01-17 NZ NZ302843A patent/NZ302843A/xx unknown
- 1996-01-17 PL PL96321365A patent/PL185422B1/pl not_active IP Right Cessation
- 1996-01-17 EP EP96905167A patent/EP0805860A2/fr not_active Withdrawn
-
1997
- 1997-08-14 BG BG101832A patent/BG62976B1/bg unknown
Non-Patent Citations (5)
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999009151A3 (fr) * | 1997-08-13 | 1999-08-05 | Univ California | Procedes et materiaux destines a conferer aux plantes une resistance aux maladies |
US6476292B1 (en) | 1998-02-26 | 2002-11-05 | Pioneer Hi-Bred International, Inc. | Methods for enhancing disease resistance in plants |
WO1999043821A1 (fr) * | 1998-02-26 | 1999-09-02 | Pioneer Hi-Bred International, Inc. | Genes activant le systeme de defense de plantes contre les elements pathogenes |
WO1999043823A1 (fr) * | 1998-02-26 | 1999-09-02 | Pioneer Hi-Bred International, Inc. | Genes activant le systeme de defense de plantes contre les elements pathogenes |
US6586657B2 (en) | 1998-02-26 | 2003-07-01 | Pioneer Hi-Bred International, Inc. | Methods for enhancing disease resistance in plants |
WO1999045129A1 (fr) * | 1998-03-06 | 1999-09-10 | Mogen International N.V. | Procede induisant une resistance aux pathogenes dans les plantes |
US6774281B1 (en) | 1998-03-06 | 2004-08-10 | Syngenta Mogen Bv | Method for the induction of pathogen resistance in plants |
WO1999064600A1 (fr) * | 1998-06-08 | 1999-12-16 | Istituto Agrario Di San Michele All'adige | SEQUENCES DE NUCLEOTIDES DU GENE LRPKm1 DE LA POMME, SEQUENCES AMINOACIDES CODEES ET LEURS MISES EN APPLICATION |
WO2000004155A3 (fr) * | 1998-07-17 | 2000-04-20 | Purdue Research Foundation | Compositions et procedes servant a augmenter la resistance de plantes a des maladies |
WO2000009698A3 (fr) * | 1998-08-14 | 2000-07-06 | Univ Kansas State | Composes s'utilisant pour rendre des plantes resistantes et procedes afferents |
WO2002010367A1 (fr) * | 2000-07-28 | 2002-02-07 | The Salk Institute For Biological Studies | Recepteurs chimeres et leurs utilisations |
WO2010046423A2 (fr) | 2008-10-22 | 2010-04-29 | Basf Se | Utilisation d'herbicides sulfonylurées sur des plantes cultivées |
WO2010046422A2 (fr) | 2008-10-22 | 2010-04-29 | Basf Se | Utilisation d'herbicides de type auxine sur des plantes cultivées |
WO2014053395A1 (fr) | 2012-10-01 | 2014-04-10 | Basf Se | Utilisation de composés de n-thio-anthranilamide sur des plantes cultivées |
WO2014079820A1 (fr) | 2012-11-22 | 2014-05-30 | Basf Se | Utilisation de composés d'anthranilamides pour réduire les infections virales véhiculées par les insectes |
EP3028573A1 (fr) | 2014-12-05 | 2016-06-08 | Basf Se | Utilisation d'un triazole fongicide sur des plantes transgéniques |
WO2016091674A1 (fr) | 2014-12-12 | 2016-06-16 | Basf Se | Utilisation de cyclaniliprole sur des plantes cultivées |
WO2016162371A1 (fr) | 2015-04-07 | 2016-10-13 | Basf Agrochemical Products B.V. | Utilisation d'un composé de carboxamide insecticide contre les nuisibles sur des plantes cultivées |
EP3338552A1 (fr) | 2016-12-21 | 2018-06-27 | Basf Se | Utilisation d'un fongicide tetrazolinone sur des plantes transgéniques |
Also Published As
Publication number | Publication date |
---|---|
BR9606918A (pt) | 1997-11-11 |
MX9705580A (es) | 1997-11-29 |
JPH11514206A (ja) | 1999-12-07 |
NZ302843A (en) | 1999-11-29 |
CA2210440A1 (fr) | 1996-07-25 |
CN1114694C (zh) | 2003-07-16 |
AU710145B2 (en) | 1999-09-16 |
CN1191573A (zh) | 1998-08-26 |
BG101832A (en) | 1998-07-31 |
WO1996022375A3 (fr) | 1996-10-17 |
HUP9802411A3 (en) | 2000-11-28 |
PL321365A1 (en) | 1997-12-08 |
PL185422B1 (pl) | 2003-05-30 |
HUP9802411A2 (hu) | 1999-01-28 |
EP0805860A2 (fr) | 1997-11-12 |
GEP20022684B (en) | 2002-04-25 |
TR199700650T1 (xx) | 1998-01-21 |
BG62976B1 (bg) | 2000-12-29 |
AU4899796A (en) | 1996-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU710145B2 (en) | Procedures and materials for conferring disease resistance in plants | |
US8334427B2 (en) | Induction of Xa27 by the avrXa27 gene in rice confers broad-spectrum resistance to Xanthomonas oryzae pv. oryzae and enhanced resistance to Xanthomonas oryzae pv. oryzicola | |
AU735665B2 (en) | Acquired resistance npr genes and uses thereof | |
JP2006055169A (ja) | Rps2遺伝子およびその使用 | |
US20060162018A1 (en) | Plant transcriptional regulators of disease resistance | |
US5859339A (en) | Nucleic acids, from oryza sativa, which encode leucine-rich repeat polypeptides and enhance xanthomonas resistance in plants | |
AU697247B2 (en) | Plant pathogen resistance genes and uses thereof | |
WO1999009151A2 (fr) | Procedes et materiaux destines a conferer aux plantes une resistance aux maladies | |
US5952485A (en) | Procedures and materials for conferring disease resistance in plants | |
US6479731B1 (en) | Pi-ta gene conferring fungal disease resistance to plants | |
US5977434A (en) | Procedures and materials for conferring disease resistance in plants | |
WO2005017158A1 (fr) | Acides nucleiques provenant du riz conferant une resistance a la brulure bacterienne causee par xanthomonas spp. | |
RU2203320C2 (ru) | Способы и вещества для придания растениям устойчивости к заболеваниям | |
WO2000008189A2 (fr) | Gene vegetal de resistance | |
AU709028B2 (en) | Plant pathogen resistance genes and uses thereof | |
US20040093633A1 (en) | Plant resistance gene | |
WO1998053073A1 (fr) | Gene indicateur de resistance aux maladies vegetales, materiaux et procedes y relatifs | |
WO2002002787A1 (fr) | Eliciteur de cladosporium | |
AU2001270611A1 (en) | Elicitor from cladosporium | |
WO2001005952A2 (fr) | Genes de plantes | |
WO1998015171A1 (fr) | Procedures et matieres permettant de conferer aux plantes une resistance aux parasites | |
US20030192074A1 (en) | Resistance gene | |
WO2001062896A2 (fr) | Determinants avirulents specifiques de xa21 provenant de xanthomonas oryzae pv. oryzae | |
MXPA01002195A (en) | A new method of identifying non-host plant disease resistance genes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 96191493.9 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AZ BY KG KZ RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AZ BY KG KZ RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 302843 Country of ref document: NZ |
|
ENP | Entry into the national phase |
Ref document number: 2210440 Country of ref document: CA Ref document number: 2210440 Country of ref document: CA Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 972986 Country of ref document: FI |
|
WWE | Wipo information: entry into national phase |
Ref document number: 97-01312 Country of ref document: RO |
|
ENP | Entry into the national phase |
Ref document number: 1996 522397 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 97/00650 Country of ref document: TR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1996905167 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1996905167 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1996905167 Country of ref document: EP |